Can a Bayesian belief network for survival prediction in patients with extremity metastases (PATHFx) be externally validated in an Asian cohort of 356 surgically treated patients?

Authors:
Hsieh HC; Lai YH; Lee CC; Yen HK; Tseng TE and 8 more

Journal:
Acta Orthop

Publication Year: 2022

DOI:
10.2340/17453674.2022.4545

PMCID:
PMC9463636

PMID:
36083697

Journal Information

Full Title: Acta Orthop

Abbreviation: Acta Orthop

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Orthopedics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Ethics, funding, and potential conflicts of interests This study was designed following the Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis guideline (15) and approved by our Research Ethics Committee (201912022RIND, Treatment effect on patients with osteolytic tumors: a retrospective study). No funding was received for this study. The authors involved in the original PATHFx studies, JF and RW, were not part of data extraction and analysis and did not have access to our original Taiwanese dataset. JF and RW are shareholders in Prognostix AB, Sweden."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025